Publicly listed company Propanc Biopharma plans to acquire US$100 million Ethereum
Source: ForesightNews
Time: 2025-09-02 21:08:59
Biopharma company Propanc Biopharma (NASDAQ:PPCB) announced plans to acquire $100 million worth of Ethereum in the next 12 months. The company said the move will enhance its corporate strategy in cryptocurrency investment, drug development and asset acquisitions.